Atmastco IPO vs Zenith Drugs IPO

Comparision between Atmastco IPO and Zenith Drugs IPO.

IPO Details

Atmastco IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Book Built Issue proposed to list at NSE SME.

	Atmastco IPO	Zenith Drugs IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Book Built Issue
Listing At	NSE SME	NSE SME
Lead Managers	Affinity Global Capital Market Private Limited	Gretex Corporate Services Limited
Registrar	Cameo Corporate Services Limited	Bigshare Services Pvt Ltd
Market Maker	Asnani Stock Broker Private Limited	Gretex Share Broking Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor		Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Atmastco IPO is up to ₹56.25 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹40.68 Cr. The final issue price of Atmastco IPO is ₹77.00 per share and of Zenith Drugs IPO is ₹79.00 per share.

	Atmastco IPO	Zenith Drugs IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹75.00 per share
Issue Price (Upper)		₹79.00 per share
Issue Price (Final)	₹77.00 per share	₹79.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	1600 shares	1600 shares
Fresh Issue Size	54,80,000 shares	51,48,800 shares
Fresh Issue Size (Amount)	up to ₹42.20 Cr	up to ₹40.68 Cr
OFS Issue Size	18,25,600 shares
OFS Issue Size (Amount)	up to ₹14.06 Cr
Issue Size Total	73,05,600 shares	51,48,800 shares
Issue Size Total (Amount)	up to ₹56.25 Cr	up to ₹40.68 Cr

IPO Timetable

Atmastco IPO opens on Feb 15, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Atmastco IPO and Zenith Drugs IPO is Feb 20, 2024, and Feb 22, 2024, respectively.

	Atmastco IPO	Zenith Drugs IPO
Anchor Bid Date		Feb 16, 2024
Issue Open	Feb 15, 2024	Feb 19, 2024
Issue Close	Feb 20, 2024	Feb 22, 2024
Basis Of Allotment (Tentative)	Feb 21, 2024	Feb 23, 2024
Initiation of Refunds (Tentative)	Feb 22, 2024	Feb 26, 2024
Credit of Share (Tentative)	Feb 22, 2024	Feb 26, 2024
Listing date (Tentative)	Feb 23, 2024	Feb 27, 2024
Anchor Lockin End date 1		Mar 24, 2024
Anchor Lockin End date 2		May 23, 2024

Financials

Atmastco IPO P/E ratio is 11.6, as compared to Zenith Drugs IPO P/E ratio of 18.4.

Atmastco IPO

Zenith Drugs IPO

Financial

Atmastco Limited Financial Information (Restated Consolidated)

Atmastco Limited's revenue increased by 156.43% and profit after tax (PAT) rose by 295.58% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Aug 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	24,391.56	23,620.72	13,273.94	12,036.21
Revenue	6,700.16	24,278.76	9,468.14	6,990.68
Profit After Tax	628.74	1,277.75	323.00	60.46
Net Worth	6,259.03	5,520.33	4,235.23	3,912.23
Reserves and Surplus	4,763.72	4,039.20	2,754.10	2,431.10
Total Borrowing	7,317.46	7,125.68	5,155.92	5,410.48
Amount in ₹ Lakhs

Zenith Drugs Limited Financial Information (Restated Consolidated)

Zenith Drugs Limited's revenue increased by 24.85% and profit after tax (PAT) rose by 64.7% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	30 Sep 2023	31 Mar 2023	31 Mar 2022
Assets	11,249.04	9,793.83	6,858.47
Revenue	6,948.43	11,569.65	9,266.63
Profit After Tax	539.38	515.29	312.86
Net Worth	2,264.96	1,724.42	1,209.09
Reserves and Surplus	1,064.96	1,684.42	1,169.09
Total Borrowing	2,902.81	2,605.03	1,880.86
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

97.39%

100.00%

Promoter Shareholding (Post-Issue)

68.43%

69.98%

P/E Ratio

11.6

18.4

Market Cap

₹190.46 Cr.

₹135.48 Cr.

ROE

23.15%%

35.13%%

ROCE

29.91%%

37.29%%

Debt/Equity

0.48

1.51

EPS

₹6.64

₹4.29

RoNW

23.15%%

29.88%%

Shares Offered

In the Atmastco IPO retail investors (RII) are offered 34,69,600 shares while in Zenith Drugs IPO retail investors are offered 34,69,600 shares. Qualified institutional buyers (QIB) are offered 0 shares in Atmastco IPO and 8,59,200 shares in Zenith Drugs IPO.

	Atmastco IPO	Zenith Drugs IPO
Anchor Investor Reserveration		12,88,000 shares
Market Maker Reserveration	3,66,400 shares	8,52,800 shares
QIB	0 shares	8,59,200 shares
NII	34,69,600 shares	6,44,800 shares
RII	34,69,600 shares	15,04,000 shares
Employee	0 shares	0 shares
Others
Total	69,39,200 shares	30,08,000 shares

Bids Received (Subscription)

Atmastco IPO subscribed 17.61x in total, whereas Zenith Drugs IPO subscribed 179.18x.

	Atmastco IPO	Zenith Drugs IPO
QIB (times)		106.72x
NII (times)	14.92x	368.77x
Big NII (times)
Small NII (times)
RII (times)	18.24x	139.28x
Employee (times)
Other (times)
Total (times)	17.61x	179.18x

Compare with others

Atmastco IPO	Zenith Drugs IPO
Deem Roll Tech IPO	M.V.K. Agro Food IPO
Zenith Drugs IPO	Owais Metal and Mineral Processing IPO
Esconet Technologies IPO	Purv Flexipack IPO
Trust Fintech IPO	Sadhav Shipping IPO
Interiors and More IPO	Deem Roll Tech IPO
Thaai Casting IPO	Esconet Technologies IPO
Kalahridhaan Trendz IPO	Trust Fintech IPO
Polysil Irrigation Systems IPO	Interiors and More IPO
Rudra Gas Enterprise IPO	Atmastco IPO
WTI Cabs IPO	Thaai Casting IPO

Comments

Add a public comment...